Home › Funds › GF FUND MANAGEMENT CO. LTD. › VRTX

GF FUND MANAGEMENT CO. LTD. position in VRTX

VERTEX PHARMACEUTICALS INC · Health Care

GF FUND MANAGEMENT CO. LTD. reported holding 62,738 shares of VRTX (VERTEX PHARMACEUTICALS INC) in its Q3 2026 13F filing — a position valued at US$32.8M, representing 0.42% of its reported portfolio and ranking #49 among its reported holdings. GF FUND MANAGEMENT CO. LTD. has disclosed VRTX holdings in 8 of the last 8 reported quarters, going back to Q4 2024.

Latest position (Q3 2026)62.74K sh
Reported value held$32.80M
Portfolio Weight0.42%
First reportedQ4 2024
Last changeHold
Updated2026-10-26

Last updated: 2026-10-26 · Source: SEC EDGAR Form 13F-HR

How GF FUND MANAGEMENT CO. LTD.'s VRTX position evolved

GF FUND MANAGEMENT CO. LTD. first disclosed a stake in VRTX in Q4 2024 at 59,178 shares (US$23.8M). The position peaked in Q3 2026 at 62,738 shares, worth US$32.8M. Across 8 filings, GF FUND MANAGEMENT CO. LTD. increased the stake 4 time(s), trimmed it 2 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 62,738 shares valued at US$32.8M.

Quarter by quarter

QuarterSharesValueChange
Q4 2024 59.18K $23.83M New
Q1 2025 60.81K $29.48M Add
Q2 2025 62.32K $27.74M Add
Q3 2025 62.79K $24.59M Add
Q4 2025 65.41K $29.65M Add
Q1 2026 64.59K $28.84M Reduce
Q2 2026 62.68K $31.13M Reduce
Q3 2026 62.74K $32.80M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About VRTX and 13F data

VRTX (VERTEX PHARMACEUTICALS INC) is a Health Care company. 33 other funds we track also report a position in VRTX — the largest reported positions include Capital World Investors (US$12.97B), Capital World Investors (US$12.97B), Capital Research Global Investors (US$9.68B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding VRTX

All VRTX fund holders →

FAQ

How long has GF FUND MANAGEMENT CO. LTD. held VRTX?

GF FUND MANAGEMENT CO. LTD. has disclosed VRTX holdings in 8 of the last 8 reported quarters, going back to Q4 2024.

What is GF FUND MANAGEMENT CO. LTD.'s current position in VRTX?

As of Q3 2026, GF FUND MANAGEMENT CO. LTD. holds 62.74K shares of VRTX (VERTEX PHARMACEUTICALS INC), valued at $32.80M, representing 0.42% of its reported portfolio and ranking #49.

Has GF FUND MANAGEMENT CO. LTD. been buying or selling VRTX?

In the latest 13F filing (Q3 2026), GF FUND MANAGEMENT CO. LTD. held unchanged its position in VRTX. The position peaked in Q3 2026 at 62.74K shares.

Which other funds hold VRTX?

Other major institutional holders of VRTX include Capital World Investors, Capital World Investors, Capital Research Global Investors, among 33 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.